NCT01038674 Safety and Tolerability of Anti-IL-20 in Subjects With Rheumatoid Arthritis Status COMPLETED Phase PHASE1
NCT01038349 Applications for Methotrexate Optimization in Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT01034397 A Study of Tocilizumab Plus Non-biological DMARD in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Non-biological DMARDs Status COMPLETED Phase PHASE4
NCT01034306 Oral CF101 Tablets Treatment in Patients With Rheumatoid Arthritis Status COMPLETED Phase PHASE2
NCT01034137 A Study of Tocilizumab and Methotrexate in Combination or as Monotherapy in Treatment-Naïve Patients With Early Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT01029613 Adalimumab in Rheumatoid Arthritis. An Investigation of Wholebody MRI, Conventional MRI, CT and Circulating Biomarkers Status COMPLETED Phase N/A
NCT01027728 Study to Evaluate Safety and Efficacy of CCX 354-C in Subjects With Rheumatoid Arthritis Status COMPLETED Phase PHASE1/PHASE2
NCT01026519 A Safety and Tolerability Study of REGN88(SAR153191) in Subjects With Rheumatoid Arthritis Status COMPLETED Phase PHASE1
NCT01023256 Safety and Preliminary Efficacy of MOR103 in Patients With Active Rheumatoid Arthritis Status COMPLETED Phase PHASE1/PHASE2
NCT01021735 Optimal Management of Rheumatoid Arthritis Patients Requiring Biologic Therapy Status COMPLETED Phase PHASE4
NCT01017367 Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (RA) Status COMPLETED Phase PHASE2
NCT01011959 A Multiple-dose Study of the Safety and Tolerability of REGN88(SAR153191) in Rheumatoid Arthritis Subjects Status COMPLETED Phase PHASE1
NCT01010581 SC12267 (4SC-101) in Combination With Methotrexate in Patients With Rheumatoid Arthritis Status COMPLETED Phase PHASE2
NCT01010503 A Study of Tocilizumab With or Without Methotrexate in Patients With Rheumatoid Arthritis. Status COMPLETED Phase PHASE4
NCT01010269 Vanguard Complete Knee Versus Vanguard High Flex Rotating Platform (RP) Knee Study Status COMPLETED Phase NA
NCT01009879 Human Tumor Necrosis Factor Alpha (TNFa)-Induced Pre-B Cell Bone Marrow Emigrants Status WITHDRAWN Phase PHASE4
NCT01009242 To Evaluate the Blood Levels and Safety of IV and Subcutaneous CDP6038 in Subjects With Rheumatoid Arthritis Using Methotrexate Status COMPLETED Phase PHASE1/PHASE2
NCT01007435 A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT01007175 Study Evaluating Multiple Ascending Doses Of ATN-103 In Japanese Subjects With Rheumatoid Arthritis Status COMPLETED Phase PHASE1/PHASE2
NCT01002716 Cell Immunity Response to Vaccination Against Influenza in Patients With Rheumatoid Arthritis Status UNKNOWN Phase PHASE4